Trump Administration Hands Out Record Number of Orphan Drug Approvals

A federal incentive for research into rare diseases for so-called orphan drugs is beloved by pharmaceutical companies. And during Donald Trump’s first two years in office, the Food and Drug Administration has been authorizing them at an unprecedented rate, according to Axios. Rare diseases are those that affect 200,000 or fewer people in the country, […]